Correlation Between Seres Therapeutics and Ocean Biomedical
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Ocean Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Ocean Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Ocean Biomedical, you can compare the effects of market volatilities on Seres Therapeutics and Ocean Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Ocean Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Ocean Biomedical.
Diversification Opportunities for Seres Therapeutics and Ocean Biomedical
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Seres and Ocean is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Ocean Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocean Biomedical and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Ocean Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocean Biomedical has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Ocean Biomedical go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Ocean Biomedical
Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the Ocean Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Seres Therapeutics is 1.68 times less risky than Ocean Biomedical. The stock trades about -0.02 of its potential returns per unit of risk. The Ocean Biomedical is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 535.00 in Ocean Biomedical on August 31, 2024 and sell it today you would lose (465.00) from holding Ocean Biomedical or give up 86.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Seres Therapeutics vs. Ocean Biomedical
Performance |
Timeline |
Seres Therapeutics |
Ocean Biomedical |
Seres Therapeutics and Ocean Biomedical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Ocean Biomedical
The main advantage of trading using opposite Seres Therapeutics and Ocean Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Ocean Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocean Biomedical will offset losses from the drop in Ocean Biomedical's long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Ocean Biomedical vs. Enveric Biosciences | Ocean Biomedical vs. Hepion Pharmaceuticals | Ocean Biomedical vs. Elevation Oncology | Ocean Biomedical vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |